RETRACTED ARTICLE: Toll-like receptor 9 (TLR9) gene deletion-mediated fracture healing in type II diabetic osteoporosis associates with inhibition of the nuclear factor-kappa B (NF-κB) signaling pathway

<p>We, the Editors and Publisher of the journal <i>Bioengineered</i>, have retracted the following article from publication.</p> <p>Han, J., Zheng, Q., Cheng, Y., Liu, Y., Bai, Y., Yan, B., Guo, S., Yu, J., Li, X., & Wang, C. (2022). Toll-like receptor 9 (TLR9) gene deletion-mediated fracture healing in type II diabetic osteoporosis associates with inhibition of the nuclear factor-kappa B (NF-κB) signaling pathway. <i>Bioengineered</i>, 13(5), 13689–13702. <a target="_blank" href="doi.org/10.1080/21655979.2022.2063663">https://doi.org/10.1080/21655979.2022.2063663</a></p> <p>Since publication, significant concerns have been raised about the integrity of the data and reported results in the article.</p> <p>When approached for an explanation, the authors did not respond to our queries and so these serious concerns remain unaddressed.</p> <p>As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article.

The authors have been informed of this decision.</p> <p>We have been informed in our decision-making by our policy on publishing ethics and integrity and COPE guidelines.</p> <p>The retracted article will remain online to maintain the scholarly record and will be digitally watermarked on each page as ‘Retracted’.</p>